VAERS Explorer
Back to explore

Report #2877997

Received Dec 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
Nov 11, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH1——

Symptoms (1)

Malaise

Symptom narrative

not feeling well; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): 2025SA343018 (Sanofi), AE-021913 (BioNTech SE). An 80-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 11Nov2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; dupilumab (DUPILUMAB), in Nov2025 as 300 mg, weekly (Lot number: FW1083, Expiration Date: 31Aug2027) subcutaneous for dermatitis atopic. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "not feeling well". The action taken for dupilumab was unknown. Batch/lot number is not provided, and it cannot be obtained.

Other medications

DUPILUMAB